Morgan Stanley Nexgel, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Nexgel, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,600 shares of NXGL stock, worth $5,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,600

Previous 1,600 -0.0%

Holding current value

$5,504

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	BUY	$2.06 - $2.38 $2,060 - $2,380	1,000 Added 166.67%	1,600 $3,000
Q2 2024 Aug 14, 2024	BUY	$2.06 - $2.38 $2,060 - $2,380	1,000 Added 166.67%	1,600 $3,000
Q1 2024 Oct 17, 2024	SELL	$1.99 - $2.96 $1,990 - $2,960	-1,000 Reduced 62.5%	600 $1,000
Q4 2023 Aug 16, 2024	SELL	$1.5 - $2.35 $1,500 - $2,350	-1,000 Reduced 62.5%	600 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.38 - $2.92 $21,114 - $44,676	-15,300 Reduced 96.23%	600 $1,000
Q4 2021 Feb 14, 2022	BUY	$2.61 - $3.52 $41,499 - $55,968	15,900 New	15,900 $41,000

Others Institutions Holding NXGL

# of Institutions

Shares Held

201K

Call Options Held

Put Options Held

View Full List

About NEXGEL, INC.

Ticker NXGL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 5,572,230
Market Cap $19.2M
Description
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...

More about NXGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account